ML339

5 Cited Publications
Revisión del cliente

Based on 5 publication(s) in Google Scholar

ML339 is a selective CXCR6 antagonist with an IC50 of 140 nM. ML339 antagonizes β-arrestin recruitment and cAMP signaling pathway of human CXCR6 receptor induced by CXCL16, with IC50 of 0.3 μM and 1.4 μM, respectively. ML339 shows weaker activity against the recruitment of β-arrestin in mouse CXCR6 receptors, with an IC50 of 18 μM. ML339 has no inhibitory effect on CXCR5,CXCR4,CXCR6 and apelin receptor (APJ), with IC50 >79 μM. ML339 has the potential to promote the development of prostate cancer research.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.88%
  • No. CAS: 2579689-83-9
  • Fòrmula: C26H32ClN3O5
  • Peso molecular:502.00
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Customer Validation & Images
In Vivo Efficacy Study
  • In Vivo Efficacy Study

Ver todos los productos específicos de isoformas CXCR

More

Ver todos los productos específicos de isoformas Arrestin

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00